Live Breaking News & Updates on Replicel Life Sciences Inc Stock Exchange

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS





For the three months ended March 31, 2023 and 2022





Notice of No Auditor. | May 31, 2023 ....

United States , Hong Kong , British Columbia , Lee Buckler , David Hall , While The Company , Mainpointe Pharmaceuticals , Technology Transfer Agreement , Given The Company , Company Stock Option Plan , Company Or Replicel , International Accounting Standards Board , Share Of The Company , Replicel Life Sciences Inc , Venture Exchange The , Venture Exchange , Party Transactions , Shiseido Company , Bus Partnership , International Financial Reporting Standards , Company Options , China Health Industry Co , National Instrument , Trichoscience Innovations Inc , Canadian Dollars , Interim Financial ,